RHOE, CXCL12 AND CXCR3 MAY IDENTIFY COMPLETE RESPONSES IN ACUTE MYELOID LEUKEMIA PATIENTS TREATED WITH TIPIFARNIB
EHA Library, Antonio Gualberto, 266619
HARMONY ALLIANCE: EUROPEAN PUBLIC-PRIVATE DATA COLLECTION LEADS THE WAY - FIRST RESULTS OF THE “PROOF-OF-PRINCIPLE” STUDY IN ACUTE MYELOID LEUKEMIA
EHA Library, Lars Bullinger, 266620
PTC299 IS A NOVEL DHODH INHIBITOR FOR USE IN TREATMENT OF AML
EHA Library, Marla Weetall, 266621
TUMOR IMMUNE ESCAPE MEDIATED BY TH17CCR4-CCR6+ CELLS AND IL-6/IL-10/IL-17A IN ACUTE MYELOID LEUKEMIA
EHA Library, Amaya Zabalza, 266635
HIGH CYTOMEGALOVIRUS VIRUS LOAD INDUCES A POTENT TUMOR-SPECIFIC CD8+ T CELL RESPONSE AND PROTECTS PATIENT IN ACUTE MYELOID LEUKEMIA FROM RELAPSE AFTER SINGLE CORD BLOOD TRANSPLANTATION
EHA Library, Zimin Sun, 266636
PHASE I DOSE ESCALATION CLINICAL TRIAL OF H3B-8800, A SPLICING MODULATOR, IN PATIENTS WITH ADVANCED MYELOID MALIGNANCIES
EHA Library, David Steensma, 266651
GEMTUZUMAB OZOGAMICINE-BASED SALVAGE THERAPIES IN REFRACTORY/RELAPSED ACUTE MYELOID LEUKEMIA PATIENTS
EHA Library, Sonia Jaramillo Segura, 266652
MARKER CHROMOSOME IS A STRONG POOR PROGNOSIS FACTOR AFTER ALLOGENEIC HSCT FOR AML PATIENTS
EHA Library, Kyok Fuse, 266667
FT-2102, AN IDH1M INHIBITOR, INDUCES MUTATION CLEARANCE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) OR MYELODYSPLASTIC SYNDROME (MDS) TREATED IN PHASE 1 DOSE ESCALATION AND EXPANSION STUDY
EHA Library, Stephane DE BOTTON, 266668
AXICABTAGENE CILOLEUCEL (AXI-CEL) IN REFRACTORY LARGE B CELL LYMPHOMA: OUTCOMES IN PATIENTS ≥ OR < 65 YEARS OF AGE IN THE PIVOTAL PHASE 1/2 ZUMA-1 STUDY
EHA Library, Sattva S. Neelapu, 266683
AXICABTAGENE CILOLEUCEL (AXI-CEL) IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B CELL LYMPHOMA: PRELIMINARY RESULTS OF EARLIER STEROID USE
EHA Library, Max S. Topp, 266684
AUTOLOGOUS STEM CELL TRANSPLANT IN DIFFUSE LARGE B CELL LYMPHOMA: SIMILAR OUTCOMES AFTER BEAM AND FEAM CONDITIONING REGIMENS
EHA Library, Bruno Loureiro, 266701
ORAL CHOP LIKE CHEMOTHERAPY IN ELDERLY PATIENTS WITH HIGH-GRADE NON HODGKIN B CELL LYMPHOMA
EHA Library, Stéphanie Guidez, 266702
PERIOPERATIVE MANAGEMENT AND OUTCOMES IN CHILDREN WITH CONGENITAL BLEEDING DISORDERS: A RETROSPECTIVE REVIEW AT A SINGLE HEMOPHILIA TREATMENT CENTER
EHA Library, Young Shil PARK, 266718
HEMOPHILIA ASSOCIATED BONE PATHOLOGY IMPACTS QUALITY OF LIFE
EHA Library, Galen Goldscheitter, 266719
IDENTIFICATION OF MIRNA SIGNATURES CORRELATING WITH CLINICAL OUTCOMES IN APLASTIC ANAEMIA
EHA Library, Lynette Chee, 266735
PNH CLONE SIZE BY FLOW CYTOMETRY AND ITS CORRELATION TO PIG GENE MUTATION
EHA Library, Dajeong Jeong, 266736
CHRONIC LYMPHOCYTIC LEUKEMIA CELLS IMPAIR MITOCHONDRIAL FITNESS IN T CELLS AND IMPEDE CAR T CELL EFFICACY
EHA Library, Jaco van Bruggen, 266751
MONOCYTIC BUT NOT GRANULOCYTIC MDSCS INCREASE WITH IBRUTINIB BUT NOT ACALABRUTINIB TREATMENT IN EM-TCL1 MICE WITH CLL, SUGGESTING A ROLE FOR ITK INHIBITION IN MONOCYTIC MDSCS
EHA Library, Arantxa Romero-Toledo, 266752
A PHASE 1 DOSE ESCALATION STUDY OF ARQ 531 IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL LYMPHOID MALIGNANCIES
EHA Library, Jennifer Woyach, 266767
PHASE 2 STUDY OF ACALABRUTINIB IN IBRUTINIB-INTOLERANT PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA
EHA Library, Kerry Rogers, 266768
LONGITUDINAL TREATMENT PATTERNS AND OUTCOMES OF CHRONIC LYMPHOCYTIC LEUKEMIA IN ISRAEL (2009-2018)
EHA Library, Ran Afik, 266783
INDIVIDUAL RESPONSE OF CML PATIENTS TO TKI DOSE REDUCTION CAN RELIABLY IDENTIFY PATIENTS WITH HIGH RISK OF MOLECULAR RELAPSE AFTER TREATMENT CESSATION
EHA Library, Andrea Gottschalk, 266784
REAL WORLD TYROSINE KINASE INHIBITOR TREATMENT PATHWAYS, MONITORING PATTERNS AND RESPONSES COMPARED WITH ELN RECOMMENDATIONS IN CHRONIC MYELOID LEUKAEMIA: FINAL ANALYSIS OF THE UK TARGET CML STUDY
EHA Library, Adam Mead, 266799
THE POTENTIAL IMPACT OF SWITCH TO SECOND GENERATION TYROSINE KINASE INHIBITORS IN CHRONIC MYELOID LEUKEMIA PATIENTS IN CHRONIC PHASE WHO HAD NO OPTIMAL RESPONSE TO 3 MONTHS OF INITIAL IMATINIB THERAPY
EHA Library, Maria Pankrashkina, 266800
MOLECULAR DIAGNOSIS OF RARE CONGENITAL ANEMIAS USING TARGETED NEXT-GENERATION SEQUENCING IN INDIAN PATIENTS
EHA Library, Rashmi DONGERDIYE, 266815
SCREENING FOR HEREDITARY SPHEROCYTOSIS IN DAILY PRACTICE: WHICH IS THE BEST ALGORITHM USING ERYTHROCYTE AND RETICULOCYTE PARAMETERS?
EHA Library, Anne-Sophie Adam, 266816
INFECTIOUS COMPLICATIONS FOLLOWING ARI-0001 CELL (A3B1:CD8:4-1BB:CD3Z CART19) TREATMENT IN ADULT AND PEDIATRIC PATIENTS WITH CD19+ RELAPSED / REFRACTORY MALIGNANCIES
EHA Library, Valentín Ortiz-Maldonado, 266831
SAFETY AND TOLERABILITY OF ALLOGENEIC, OFF-THE SHELF PLACENTAL NATURAL KILLER CELLS (PNK 007) IN PHASE 1 MULTIPLE MYELOMA AND ACUTE MYELOID LEUKEMIA STUDIES (NCT02955550 AND NCT02781467)
EHA Library, Sharmila Koppisetti, 266832
ACTIVATION OF AUTOPHAGY IN ENDOTHELIAL CELLS ENHANCES HEMATOPOIETIC STEM CELLS
EHA Library, Xie-Na Cao, 266848
RAPID MAST CELL GENERATION FROM GATA2 REPORTER HUMAN PLURIPOTENT STEM CELLS
EHA Library, Carmen Rodriguez Seoane, 266849
EZH2 GAIN-OF-FUNCTION MUTATIONS ARE NOT ASSOCIATED WITH MORE FAVORABLE PROGNOSIS IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: A PRELIMINARY ANALYSIS ON 590 PATIENTS
EHA Library, Jessica Okosun, 266864
COMPREHENSIVE ANALYSIS OF BASELINE OUTCOME BIOPREDICTORS IN YOUNGER PATIENTS WITH MANTLE CELL LYMPHOMA: THE ANCILLARY BIOLOGICAL STUDIES OF FONDAZIONE ITALIANA LINFOMI (FIL) MCL0208 CLINICAL TRIAL
EHA Library, Simone Ferrero, 266865
CONSOLIDATION THERAPY USING 90Y-IBRITUMOMAB TIUXETAN AFTER BENDAMUSTINE AND RITUXIMAB IN PATIENTS WITH RELAPSED FOLLICULAR LYMPHOMA; A MULTICENTER, PHASE II STUDY (BRIZ2012)
EHA Library, Hideki Tsujimura, 266880
FRENCH IBRUTINIB OBSERVATIONAL STUDY (FIRE): REAL-WORLD STUDY OF IBRUTINIB TREATMENT FOR MANTLE CELL LYMPHOMA (MCL) IN FRANCE
EHA Library, Steven Le Gouill, 266881
A PRACTICAL UPDATE ON THE EPIDEMIOLOGY AND RISK FACTORS FOR THE EMERGENCE AND MORTALITY OF BLOODSTREAM INFECTIONS IN 3014 PATIENTS WITH HEMATOLOGICAL MALIGNANCY RECEIVING CHEMOTHERAPY
EHA Library, zhen Chen, 266896
FUNGAL INFECTIONS IN ACUTE MYELOID LEUKEMIA IN THE POSACONAZOLE ERA
EHA Library, Carolina Marini, 266897
IRON IN THE HUMAN HEARTS: DISTRIBUTION AND ASSOCIATION WITH R2* VALUES BY CMR
EHA Library, Antonella Meloni, 266912
ERYTROCYTAPHERESIS IN ACERULOPLASMINEMIA PREVENTS PROGRESSION OF CEREBRAL IRON ACCUMULATION AFTER CHELATOR-INDUCED NORMALIZATION OF IRON STORES
EHA Library, Michel van Gelder, 266913
PI3K-INHIBITION INCREASES APOPTOTIC PRIMING IN T-CELL LYMPHOMAS AND SYNERGIZES WITH BH3 MIMETICS.
EHA Library, Gerrit Nothnick, 266928
QPCR, MFC AND DDPCR: COMPARISON ON MRD SAMPLES FROM THREE PROSPECTIVE TRIALS OF THE EUROPEAN MCL NETWORK
EHA Library, Daniela Drandi, 266929
PRO-NECROPTOTIC RIPK3 AS A STAGE-DEPENDENT MARKER IN THE BONE MARROW OF PATIENTS WITH MDS AND CMML
EHA Library, Veronika Dill, 266944
ABNORMAL LEVELS OF FUNCTIONAL CTLS ON HIGH RISK MDS PATIENTS UNDER AZACYTIDINE TREATMENT
EHA Library, Zoi Bezirgiannidou, 266945
ARE MYELODYSPLASTIC SYNDROMES WITH ISOLATED 20Q DELETION A DIFFERENT CLINICAL-BIOLOGICAL ENTITY?
EHA Library, Alessia Campagna, 266960
PHASE 1/2 STUDY OF DSP-7888 IN PATIENTS WITH HIGHER-RISK (HR) MYELODYSPLASTIC SYNDROMES (MDS) AFTER FAILURE OF AZACITIDINE (AZA) THERAPY
EHA Library, Kensuke Usuki, 266961
BIDIRECTIONAL MITOCHONDRIAL TRANSFER BETWEEN MYELOMA CELLS AND BONE MARROW STROMAL CELLS CONTRIBUTES TO THE CHEMORESISTANCE OF MYELOMA CELLS
EHA Library, Zsolt Matula, 266978
TRYPTOPHAN DEPRIVATION DUE TO INCREASED IDO-1 TRIGGERS A METABOLIC ADAPTIVE RESPONSE AND DOWN-REGULATES CD38 IN MULTIPLE MYELOMA
EHA Library, Alessandra Romano, 266979
IMPROVEMENT IN HEALTH-RELATED QUALITY OF LIFE FOR NEWLY DIAGNOSED MULTIPLE MYELOMA TRANSPLANT-ELIGIBLE PATIENTS TREATED WITH DARATUMUMAB, BORTEZOMIB, THALIDOMIDE, AND DEXAMETHASONE: CASSIOPEIA STUDY
EHA Library, Murielle Roussel, 266994
AN EARLY, WITHIN THE FIRST MONTH, AND DEEP RESPONSE, SHOULD BE THE GOAL OF THERAPY IN AL AMYLOIDOSIS
EHA Library, Efstathios Kastritis, 266995
PRIMARY TREATMENT OF LIGHT CHAIN (AL) AMYLOIDOSIS WITH BORTEZOMIB, LENALIDOMIDE AND DEXAMETHASONE (VRD)
EHA Library, Efstathios Kastritis, 267010
FLOW-MEDIATED DILATATION AND AORTIC BLOOD PRESSURE PREDICT CARDIOVASCULAR ADVERSE EVENTS DURING CARFILZOMIB TREATMENT: A PROSPECTIVE STUDY IN PATIENTS WITH RELAPSED/ REFRACTORY MULTIPLE MYELOMA.
EHA Library, Efstathios Kastritis, 267011
RESULTS OF THE FREQUENCY AND CAUSES OF DISCONTINUATION OF THE SUCESIVE THERAPEUTIC LINES IN PATIENTS WITH MULTIPLE MYELOMA: REAL LIFE DATA FROM A SINGLE SPANISH CENTER
EHA Library, Ana García Feria, 267026
DARATUMUMAB IS WELL TOLERATED AND INDUCES A RAPID HEMATOLOGICAL RESPONSE IN NON IG-M LIGHT CHAIN AMYLOIDOSIS WITH SEVERE CARDIAC IMPAIRMENT.
EHA Library, Romain Gounot, 267027
THE CRAB SCORE: A SIMPLE PROGNOSTIC TOOL IN MULTIPLE MYELOMA
EHA Library, Helena Bean, 267041
RESULTS OF THE DARATUMUMAB MONOTHERAPY EARLY ACCESS TREATMENT PROTOCOL (EAP) IN PATIENTS FROM EUROPE AND RUSSIA WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
EHA Library, Gordon Cook, 267042
IMMUNE CHECKPOINT (PD-1, PD-L1, PD-L2, AND CTLA-4) EXPRESSION IN PLASMA CELL MYELOMA
EHA Library, Min Young Lee, 267043
A NOVEL ACTIVATING TPOR MUTATION IN ESSENTIAL THROMBOCYTHEMIA POINTS TO AN ACTIVATING EFFECT OF TRYPTOPHAN AND AROMATICS AT THE OUTSET OF THE TRANSMEMBRANE DOMAIN
EHA Library, Gabriel Levy, 267058
PROTEASOME INHIBITOR CARFILZOMIB HAS SYNTHETIC LETHALITY WITH RUXOLITINIB IN MYELOPROLIFERATIVE NEOPLASMS
EHA Library, Simone Claudiani, 267059
MAINTENANCE OF RESPONSE IN LONG-TERM TREATMENT WITH ROPEGINTERFERON ALFA-2B (BESREMI®) VS. HYDROXYUREA IN POLYCYTHEMIA VERA PATIENTS (PROUD/CONTINUATION-PV PHASE III TRIALS)
EHA Library, Heinz Gisslinger, 267074
RISK FACTORS AND OUTCOME OF ACUTE MYELOID LEUKEMIA SECONDARY TO POST-POLYCYTHEMIA VERA AND POST-ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS: AN ANALYSIS OF THE MYSEC COHORT
EHA Library, Barbara Mora, 267075
FEDRATINIB IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASM (MPN)-ASSOCIATED MYELOFIBROSIS (MF) PREVIOUSLY TREATED WITH RUXOLITINIB (RUX): A REANALYSIS OF THE PHASE 2 JAKARTA-2 STUDY
EHA Library, Claire Harrison, 267076
ULTRASONOGRAPHY VS RM FOR SPLEEN VOLUME EVALUATION IN MYELOPROLIFERATIVE NEOPLASMS: WHAT YOU NEED TO KNOW.
EHA Library, Novella Pugliese, 267090
NON-HODGKIN LYMPHOMA IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS
EHA Library, Kentaro Yoshinaga, 267091
COATED PLATELET FUNCTION IS RELATED TO BLEEDING PHENOTYPE IN PATIENTS WITH INHERITED THROMBOCYTOPENIA
EHA Library, Nanna Broens, 267092
BERBERINE MAY CORRECT GUT MICROBIOTA-INDUCED CORTICOSTEROID RESISTANCE AND MESENCHYMAL STEM CELL DYSFUNCTION IN IMMUNE THROMBOCYTOPENIA BY REGULATING GUT MICROBIOTA STRUCTURE
EHA Library, Yanan Wang, 267107
PLATELET KINETICS IN PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIA TREATED WITH THROMBOPOIETIN RECEPTOR AGONISTS
EHA Library, Zlatko Pravdic, 267108
ASSESSING TREATMENT RESPONSE IN CONGENITAL THROMBOTIC THROMBOCYTOPENIC PURPURA WITH AN INNOVATIVE SHEAR FLOW-BASED ASSAY
EHA Library, Chiara Vendramin, 267109
INCREASED VOC FREQUENCY ASSOCIATED WITH REDUCED HRQOL AMONG PATIENTS WITH SCD
EHA Library, Miranda Bailey, 267124
QUALITY OF LIFE AND PERCEPTION OF HEALTH CARE IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES IN THE UK
EHA Library, Esther OLIVA, 267125
QUALITY OF LIFE IN PATIENTS WITH RRMM DURING IXA-THAL-DEX INDUCTION AND IXAZOMIB MAINTENANCE THERAPY IN COMPARISON TO THE GENERAL POPULATION
EHA Library, Heinz Ludwig, 267126
THE OXYGENSCAN: A COMPREHENSIBLE FUNCTIONAL RED BLOOD CELL TEST TO MONITOR TREATMENT EFFICACY IN PATIENTS WITH SICKLE CELL DISEASE
EHA Library, Minke Rab, 267140
WHEN IS A CT NEEDED TO DIAGNOSE ACUTE PULMONARY EMBOLISM IN INDIVIDUALS WITH SICKLE CELL DISEASE
EHA Library, Nadirah El-Ahmin, 267141
ANTISICKLING EFFECTS OF 1,2,3-TRIAZOLE DERIVATIVES AS POTENTIAL NEW DRUGS FOR SICKLE CELL DISEASE
EHA Library, CLEMILSON BERTO JUNIOR, 267142
A COMPARISON OF POST ALLOGENEIC STEM CELL TRANSPLANT CHIMERISM ANALYSIS METHODS: HIGH THROUGHPUT SNP GENOTYPING ANALYSED BY MALDI-TOF MASS SPECTROMETRY VS. SHORT TANDEM REPEAT (STR) MARKER ANALYSIS.
EHA Library, Kerry Wall, 267156
MULTIPARAMETRIC PREDICTIVE SCORE FOR GRAFT VERSUS HOST DISEASE (GVHD) IN PATIENTS SUBMITTED TO ALLOGENEIC STEM CELLS TRANSPLANTATION (SCT)
EHA Library, Alessandro TURRA, 267157
OUTCOMES OF AUTOLOGOUS AND ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR BPDCN
EHA Library, Muzaffar Qazilbash, 267158
BRUTON TYROSINE KINASE INHIBITOR IS AN EFFECTIVE STEROID-SPARING AGENT IN CHRONIC GRAFT-VERSUS-HOST DISEASE
EHA Library, Osman Ilhan, 267173
EARLY ENGRAFTMENT OF UNRELATED CORD BLOOD TRANSPLANTATION IN PATIENTS WITH ACQUIRED SEVERE APLASTIC ANEMIA USING CONDITIONING REGIMEN WITHOUT ANTI-THYMOCYTE GLOBULIN
EHA Library, Xiang WAN, 267174
COMPARISON OF THE INCIDENCE AND OUTCOMES OF TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY BETWEEN HAPLOIDENTICAL AND MATCHED SIBLING DONOR HEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Library, Ruo-Yun Gui, 267175
Β0 VS. NON-Β0 GENOTYPE: DIFFERENCES IN TDT PATIENTS
EHA Library, Antonella Meloni, 267190
HLA-DRB1*15 INCREASES THE RISK OF RED BLOOD CELLS ALLOANTIBODIES IN PATIENTS WITH BETA THALASSEMIA MAJOR
EHA Library, Louza Al Mashaykhi, 267191
USE OF THE NEW DEFERASIROX FORMULATION IN PEDIATRIC THALASSEMIA PATIENTS: ONE YEAR RESULTS
EHA Library, Aikaterini Teli, 267192
RETROSPECTIVE ANALYSIS OF HEMOGLOBIN LEVEL IN 500 TRANSFUSION EVENTS AS A STUDY MODEL FOR THE EVALUATION OF TRANSFUSION APPROPRIATENESS
EHA Library, Roberto Crocchiolo, 267206
CENTRAL VEIN CATHETERIZATION IN ONCOHEMATOLOGICAL PRACTICE: RISK OF COMPLICATIONS
EHA Library, Nikolay Romanenko, 267207
FUNCTIONAL PROPERTIES OF THE HEMOGLOBIN FROM STORED RED BLOOD CELLS CONCENTRATES AFTER LEUKOREDUCTION
EHA Library, Susan Jorge, 267208
INACTIVATION OF SH2B3 THROUGH CN-LOH 12Q IS UNIQUELY ASSOCIATED WITH B-CELL PRECURSOR ALL WITH IAMP21 OR OTHER CHROMOSOME 21 GAIN.
EHA Library, Paul Sinclair, 267222
BENEFITS OF RNA SEQUENCING IN DETECTING RECURRENT AND NOVEL FUSION TRANSCRIPTS IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Rabia Shahswar, 267223
ONCOGENIC COOPERATION BETWEEN TAL1 EXPRESSION AND PI3K/AKT PATHWAY ACTIVATION IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Naomi Thielemans, 267224
CAR-T CELL THERAPY BRIDGING TO ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION LED TO SUPERIOR SURVIVAL FOR ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS OUT OF REMISSION
EHA Library, Xiaohui Hu, 267240
COMBINATION BCL-2 INHIBITOR THERAPY WITH VENETOCLAX AND NAVITOCLAX IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA AND LYMPHOBLASTIC LYMPHOMA
EHA Library, Vinod A. Pullarkat, 267241
ANTI-CD19 CAR-T THERAPY BRIDGING TO ALLO-HSCT IMPROVES LONG-TERM OUTCOME OF B-ALL PATIENTS WITH HIGH LEUKEMIA BURDEN OR POOR PROGNOSTIC MARKERS
EHA Library, Heng Mei, 267242
FEASIBLE OUTCOME OF BLINATUMOMAB FOLLOWED BY ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR ADULTS WITH RELAPSED OR REFRACTORY PHILADELPHIA-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Jae-Ho Yoon, 267256
A MULTICENTER, RETROSPECTIVE STUDY TO EVALUATE EFFICACY AND SAFETY OF BUSULFAN/FLUDARABINE CONDITIONING FOR ALLOGENEIC STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Seung-Shin Lee, 267257
INITIAL SAFETY AND EFFICACY OF LAROTRECTINIB IN PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (ALL): DATA FROM AN EXPANDED ACCESS PROGRAM
EHA Library, Denis Schewe, 267258
AT1413 ANTIBODY DERIVED FROM A CURED AML PATIENT RECOGNIZES A UNIQUE CD43 EPITOPE SHARED BY AML, MDS AND MELANOMA AND HAS IN VIVO ACTIVITY AS UNMODIFIED ANTIBODY AND AS BISPECIFIC T CELL ENGAGER
EHA Library, Greta de Jong, 267272
THE AML SECRETOME AND T CELL FUNCTION: MODULATION OF AMG 330-MEDIATED T CELL PROLIFERATION AND CYTOTOXICITY
EHA Library, Anna Maier, 267273
BCL-XL AS A PUTATIVE THERAPY TARGET IN ACUTE ERYTHROID LEUKEMIA
EHA Library, Heikki Kuusanmäki, 267274
ABNORMAL DNA METHYLATION MODIFIES HOX GENES EXPRESSION IN BONE MARROW MESENCHYMAL STROMAL CELLS OF MYELODYSPLASIAS AND DE NOVO ACUTE MYELOID LEUKEMIAS
EHA Library, Benjamin Roux, 267290
INTEGRATED ANALYSIS OF NTAL RELATED GENES IMPROVES OUTCOMES PREDICTION OF EUROPEAN LEUKEMIANET 2008 RISK STRATIFICATION IN ACUTE MYELOID LEUKEMIA
EHA Library, Diego Antonio Pereira-Martins, 267291
CA-4948, AN IRAK4/FLT3 INHIBITOR, SHOWS ANTILEUKEMIC ACTIVITY IN MOUSE MODELS OF FLT3 WILD-TYPE AND FLT3 MUTATED ACUTE MYELOID LEUKEMIA (AML)
EHA Library, Robert Booher, 267292

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.


Save Settings